ATEC
Alphatec Holdings, Inc. · Healthcare
Insiders bought $2.0M of Alphatec Holdings, Inc. in the last 12 months
2 insiders bought on 2 days.
ATEC over the last year
Largest buyers, last 12 months
ATEC after insider buys
3 months after each buy, from the first price a copier could get.
6 buys since 2019 with 3 months of prices.
Every filing
148 insider filings since 2016, newest first
David Sponsel · EVP, Sales
Patrick Miles · CEO
Patrick Miles · CEO
James L L Tullis · Director
David H Mowry · Director
Evan Bakst · Director
Jennifer N. Pritzker · 10% owner
Craig E Hunsaker · EVP, People, Culture, GC
Elizabeth Ann Altman · Director
David Sponsel · EVP, Sales
Paul Segal · Director
Craig E Hunsaker · EVP, People, Culture, GC
L-5 Healthcare Partners, LLC · Director by deputization, 10%
Paul Segal · 10% owner
Jennifer N. Pritzker · 10% owner
Craig E Hunsaker · EVP, People, Culture, GC
John Todd Koning · CFO
David R Pelizzon · Director and 10% owner
Patrick Miles · CEO
James L L Tullis · Director
Jennifer N. Pritzker · 10% owner
David Sponsel · EVP, Sales
Patrick Miles · CEO
Craig E Hunsaker · EVP, People, Culture, GC
Craig E Hunsaker · EVP, People, Culture, GC
Scott Lish · SVP, Development
John Todd Koning · CFO
John Todd Koning · CFO
Scott Lish · SVP, Development
Craig E Hunsaker · EVP, People, Culture, GC
Craig E Hunsaker · EVP, People, Culture, GC
Patrick Miles · CEO
Patrick Miles · CEO
Craig E Hunsaker · EVP, People, Culture, GC
David Sponsel · EVP, Sales
James L L Tullis · Director
David Sponsel · EVP, Sales
David Sponsel · EVP, Sales
David H Mowry · Director
Elizabeth Ann Altman · Director
Craig E Hunsaker · EVP, People, Culture, GC
Jennifer N. Pritzker · 10% owner
Craig E Hunsaker · EVP, People, Culture, GC
Craig E Hunsaker · EVP, People, Culture, GC
Patrick Miles · CEO
Jennifer N. Pritzker · 10% owner
James L L Tullis · Director
Jennifer N. Pritzker · 10% owner
Scott Lish · SVP, Development
Scott Lish · SVP, Development
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.